scispace - formally typeset
Journal ArticleDOI

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

TLDR
In patients with laryngeal cancer, radiotherapy with concurrent administration of cisplatin is superior to induction chemotherapy followed by radiotherapy or radiotherapy alone for larynGEal preservation and locoregional control.
Abstract
Background Induction chemotherapy with cisplatin plus fluorouracil followed by radiotherapy is the standard alternative to total laryngectomy for patients with locally advanced laryngeal cancer. The value of adding chemotherapy to radiotherapy and the optimal timing of chemotherapy are unknown. Methods We randomly assigned patients with locally advanced cancer of the larynx to one of three treatments: induction cisplatin plus fluorouracil followed by radiotherapy, radiotherapy with concurrent administration of cisplatin, or radiotherapy alone. The primary end point was preservation of the larynx. Results A total of 547 patients were randomly assigned to one of the three study groups. The median follow-up period was 3.8 years. At two years, the proportion of patients who had an intact larynx after radiotherapy with concurrent cisplatin (88 percent) differed significantly from the proportions in the groups given induction chemotherapy followed by radiotherapy (75 percent, P=0.005) or radiotherapy alone (70 ...

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis

TL;DR: Compared with CRT, S+PORT was associated with improved survival for locally advanced OCSCCs, especially in T3 to T4a disease, and these data support the use of surgery as the initial treatment modality for operable O CSCCs.
Journal ArticleDOI

Supracricoid Partial Laryngectomy for Primary and Recurrent Laryngeal Cancer

TL;DR: This Retrospective case series demonstrates excellent local control for both primary and recurrent laryngeal cancers, with functional larynx preservation, and SCPL should be considered as a treatment alternative to non-surgical treatment or totallaryngectomy.
Journal ArticleDOI

Metabolic abnormalities associated with weight loss during chemoirradiation of head-and-neck cancer

TL;DR: Weight loss during cisplatin-containing chemo-RT was found to be associated with reduced kidney function and highlighted the importance of intensive supportive measures of nutrition and hydration beyond standard hydration during cis Platin administration.
Journal ArticleDOI

An NIR Discrete Metallacycle Constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for Imaging‐Guided Cancer Radio‐Chemotherapy

TL;DR: In this article , a theranostic metallacycle (M) is developed for imaging-guided cancer radio-chemotherapy using perylene bisimide fluorophore (PPy) and tetraphenylethylene-based di-Pt(II) organometallic precursor (TPE)-Pt) as building blocks.
Journal ArticleDOI

Primary staging of laryngeal and hypopharyngeal cancer: CT, MR imaging and dual-energy CT.

TL;DR: Radiologists need to understand the advantages and limitations of each imaging modality for staging of laryngeal and hypopharyngeAL cancer.
References
More filters
Book ChapterDOI

Nonparametric Estimation from Incomplete Observations

TL;DR: In this article, the product-limit (PL) estimator was proposed to estimate the proportion of items in the population whose lifetimes would exceed t (in the absence of such losses), without making any assumption about the form of the function P(t).
Journal ArticleDOI

A Multiple Comparison Procedure for Comparing Several Treatments with a Control

TL;DR: In this article, a multiple comparison procedure for comparing several treatments with a control is presented, which is based on the Multiple Comparison Procedure for Comparing Several Treatments with a Control (MCPC).
Journal ArticleDOI

A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk

Robert Gray
- 01 Jan 1988 - 
TL;DR: In this paper, a class of tests developed for comparing the cumulative incidence of a particular type of failure among different groups is presented. The tests are based on comparing weighted averages of the hazards of the subdistribution for the failure type of interest.
Journal ArticleDOI

Cancer statistics, 2003.

TL;DR: The American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year, and compiles the most recent data on cancer incidence, mortality, and survival by using incidence data from the National Cancer Institute (NCI) and mortality data from National Center for Health Statistics (NCHS).
Related Papers (5)